Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxoprofen Sodium Eye Drops for Postoperative Inflammation and Pain After Cataract Surgery
CTR20222801Phase 2Completed
- Sponsor
- Guangzhou Aobo Pharmaceutical Technology
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of loxoprofen in post-operative inflammation, postoperative pain, cataract, sponsored by Guangzhou Aobo Pharmaceutical Technology. Started Oct 2022; status: completed.
02
Drugs
loxoprofen
03
Conditions
post-operative inflammationpostoperative paincataract
Beyond the preview
Go deeper on CTR20222801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222801.